Multi-Tissue Metabolomic Signatures Of Five Longevity Interventions Converge On Ergothioneine And Lipid Remodeling In Male UM-Het3 Mice
Scientists are constantly working to understand how we can slow down the aging process. While we know that things like diet and certain medications can help extend lifespan, the exact metabolic changes that occur within the body are still being uncovered. A recent study delved into this by examining male mice treated with five different interventions known to promote longevity: rapamycin, acarbose, 17α-estradiol, canagliflozin, and caloric restriction.
Using a comprehensive approach called metabolomics, which looks at all the small molecules (metabolites) in different tissues, the researchers found some fascinating commonalities. One of the most striking discoveries was that a specific dietary antioxidant, ergothioneine, was consistently elevated in the plasma and brain of mice across all five interventions, and in muscle for four out of five. This suggests that ergothioneine might play a crucial role in the body’s response to these longevity-promoting strategies.
Beyond ergothioneine, the study also highlighted significant and coordinated changes in various types of lipids (fats) in tissues like plasma, fat around organs, and the kidneys. This “lipid remodeling” indicates that how the body processes and stores fats is a key aspect of how these interventions work. These findings suggest that despite their different mechanisms, various longevity interventions might converge on similar metabolic pathways, offering new avenues for identifying and developing future anti-aging therapies.
Source: link to paper